Insights

Niche Therapeutic Focus LATINABA specializes in developing treatments across a broad range of therapeutic areas including rare diseases, orphan drugs, and gene therapy, presenting opportunities to collaborate with biotech firms and specialized healthcare providers seeking innovative solutions in these high-need markets.

Emerging Market Presence With operations spanning multiple countries and a focus on local country management, LATINABA is positioned to expand its footprint in Latin America and other emerging markets, appealing to regional partners and distributors aiming to enhance access to advanced therapies.

Early Revenue Stage The company's revenue range of $0 to 1 million indicates a growing pipeline, presenting opportunities for investors or partners interested in early-stage development projects or clinical trial collaborations to accelerate product commercialization.

Technological Foundation Utilizing cloud services and modern web technologies, LATINABA demonstrates a scalable and adaptable platform that could facilitate partnerships in digital health, clinical data management, and remote monitoring solutions for clinical trials.

Potential for Strategic Alliances Given the company's extensive therapeutic expertise and emerging product portfolio, there are opportunities to form strategic alliances with larger pharmaceutical or biotech companies aiming to expand their pipeline in specialized and rare disease segments.

LATINABA Tech Stack

LATINABA uses 8 technology products and services including Amazon Web Services, oEmbed, OWL Carousel, and more. Explore LATINABA's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • oEmbed
    Dev Tools
  • OWL Carousel
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Google Maps
    Maps
  • Slider Revolution
    Miscellaneous
  • Bootstrap
    UI Frameworks
  • Contact Form 7
    Web Platform Extensions

Media & News

LATINABA's Email Address Formats

LATINABA uses at least 2 format(s):
LATINABA Email FormatsExamplePercentage
First@blanchardyasociados.comJohn@blanchardyasociados.com
100%

Frequently Asked Questions

Where is LATINABA's headquarters located?

Minus sign iconPlus sign icon
LATINABA's main headquarters is located at 1172 South Dixie Highway, Suite# 442. The company has employees across 2 continents, including South AmericaNorth America.

What is LATINABA's official website and social media links?

Minus sign iconPlus sign icon
LATINABA's official website is latinaba.com and has social profiles on LinkedIn.

What is LATINABA's NAICS code?

Minus sign iconPlus sign icon
LATINABA's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does LATINABA have currently?

Minus sign iconPlus sign icon
As of December 2025, LATINABA has approximately 19 employees across 2 continents, including South AmericaNorth America. Key team members include Ceo: M. Z.Finance Manager And Cfo: C. V.Project Manager: T. T.. Explore LATINABA's employee directory with LeadIQ.

What industry does LATINABA belong to?

Minus sign iconPlus sign icon
LATINABA operates in the Pharmaceutical Manufacturing industry.

What technology does LATINABA use?

Minus sign iconPlus sign icon
LATINABA's tech stack includes Amazon Web ServicesoEmbedOWL CarouselModernizrGoogle MapsSlider RevolutionBootstrapContact Form 7.

What is LATINABA's email format?

Minus sign iconPlus sign icon
LATINABA's email format typically follows the pattern of First@blanchardyasociados.com. Find more LATINABA email formats with LeadIQ.

When was LATINABA founded?

Minus sign iconPlus sign icon
LATINABA was founded in 2008.

LATINABA

Pharmaceutical ManufacturingFlorida, United States11-50 Employees

Our Senior Management Team includes: 
CEO and Clinical Operations Officer.
Chief Scientific Officer
Country Management in all of our countries 
CFO/Finance Manager
Legal Affairs
Regulatory Affairs
Training Management
Quality Assurance

Our experience covers several therapeutic areas and 
- perinatal and pediatric population 
- includes gene therapy clinical studies
- includes medical device studies
- covers indications including orphan drugs and rare diseases.

Anti Infectives
Chagas Disease
Hepatitis C
Hepatitis B
HIV / AIDS
Herpes Simplex
Community Acquired Pneumonia
ADRS
Influenza

Cardiovascular
Abdominal Aorta Aneurism
Atrial Fibrillation
Cardiovascular Risk & Osteoporosis
Cardiovascular Risk & Diabetes
Congestive Heart Failure
Coronary Lesions
Hypertension
Heart Failure

Central Nervous System
Epilepsy
Alzheimer
Depression
Bipolar Disorder
Multiple Sclerosis
Anxiety Disorder
Smoking Cessation
Adrenoleukodystrophy
Spasticity
Dermatology
Acne Vulgaris
Actinic Keratosis
Psoriasis
Cutaneous Leishmaniosis
Melasma
Tinea pedis
Impetigo

Immunology
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Hereditary Angiedema

Oncology
Breast Cancer
Cervix Cancer
Chronic Myeloid Leukemia
Colorectal Cancer
Gist (QOL)
Lung Cancer
Melanoma
Prostate Cancer
Head & Neck Cancer

Ophthalmology
Uveitis
Glaucoma
Keratoconjunctivitis

Vaccines
H1N1 Influenza
Respiratory Syncytial Virus
Hookworm

Endocrino-Metabolics
Osteoporosis
Hipercholesterolaemia
Diabetes M. Type I and II
Early Puberty

Other Indications
Stroke
COPD
Von Willebrand Disease
Renal Impairment
Traumatic Brain Injury
Primary Biliary Cirrhosis
Hemophilia

Section iconCompany Overview

Headquarters
1172 South Dixie Highway, Suite# 442
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2008
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M

    LATINABA's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    LATINABA's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.